12:00 AM
 | 
May 21, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cytos completes rights offering

Cytos Biotechnology AG (SIX: CYTN), Schlieren, Switzerland
Business: Neurology, Inflammation, Cardiovascular
Date completed: 5/10/12...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >